The lysosomal disease treatments market is growing due to increasing prevalence of rare genetic disorders and advancements in enzyme replacement therapies. These diseases affect cellular metabolism and require long-term medical management. Market growth is driven by rising investments in orphan drug development, improved diagnostic tools, and supportive regulatory frameworks. https://www.databridgemarketresearch.com/reports/global-lysosomal-disease-treatments-market